Biotech Values

[ghmm]

CRME:

Hi genisi,

Thanks for pointing out that observation.

About the fatality in the IV, the docs day:
It is very likely that the fatality was precipitated by the
subject’s aortic stenosis and heart failure, but there are not enough data in this program that would lend support to this hypothesis.
Do you think there is enough room to speculate the drug may not have been related in that case as well?

I am more interested in the oral program. I would like to see both formulation succeed though. Do you know if the other approved (oral) drugs have had any associated moratility or SAE's?